Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa

  • Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients 
  • Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years

  • Researchers based at universities, science councils and other public research organizations across Africa are invited to express ‘intent to submit’ by March 1, 2021

Basel, January 19, 2021 — Novartis and GSK today announced the …

/by